{
    "Trade/Device Name(s)": [
        "David Pregnancy Test (Strip and Midstream)"
    ],
    "Submitter Information": "National Business Group Inc.",
    "510(k) Number": "K053236",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCX"
    ],
    "Summary Letter Date": "September 26, 2006",
    "Summary Letter Received Date": "June 22, 2006",
    "Submission Date": "June 19, 2006",
    "Regulation Number(s)": [
        "21CFR862.1155"
    ],
    "Regulation Name(s)": [
        "Human chorionic gonadotropin (HCG) test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Human chorionic gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunoassay"
    ],
    "Methodologies": [
        "Qualitative immunoassay"
    ],
    "Submission Type(s)": [
        "Test",
        "Kit",
        "Strip",
        "Midstream"
    ],
    "Document Summary": "FDA 510(k) summary for David Pregnancy Test (Strip and Midstream), an over-the-counter qualitative immunoassay for detecting hCG in urine.",
    "Indications for Use Summary": "A self-testing immunoassay for the qualitative determination of human chorionic gonadotropin (hCG) in urine to aid in early detection of pregnancy for over-the-counter use.",
    "fda_folder": "Clinical Chemistry"
}